﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2011v1.2">
  <ReturnHeader binaryAttachmentCount="0">
    <Timestamp>2012-06-21T06:58:12-05:00</Timestamp>
    <TaxPeriodEndDate>2011-12-31</TaxPeriodEndDate>
    <PreparerFirm>
      <PreparerFirmBusinessName>
        <BusinessNameLine1>YEO &amp; YEO PC</BusinessNameLine1>
      </PreparerFirmBusinessName>
      <PreparerFirmUSAddress>
        <AddressLine1>455 E EISENHOWER PKWY STE 102</AddressLine1>
        <City>ANN ARBOR</City>
        <State>MI</State>
        <ZIPCode>481083321</ZIPCode>
      </PreparerFirmUSAddress>
    </PreparerFirm>
    <ReturnType>990</ReturnType>
    <TaxPeriodBeginDate>2011-01-01</TaxPeriodBeginDate>
    <Filer>
      <EIN>861087705</EIN>
      <Name>
        <BusinessNameLine1>SARC</BusinessNameLine1>
      </Name>
      <NameControl>SARC</NameControl>
      <Phone>7349307600</Phone>
      <USAddress>
        <AddressLine1>24 FRANK LLOYD WRIGHT DRIVE</AddressLine1>
        <AddressLine2>ROOM/SUITE 3100</AddressLine2>
        <City>ANN ARBOR</City>
        <State>MI</State>
        <ZIPCode>48106</ZIPCode>
      </USAddress>
    </Filer>
    <Officer>
      <Name>DENISE REINKE</Name>
      <Title>PRESIDENT, COO</Title>
      <Phone>7349307600</Phone>
      <DateSigned>2012-06-14</DateSigned>
      <AuthorizeThirdParty>true</AuthorizeThirdParty>
    </Officer>
    <Preparer>
      <Name>THOMAS A O'SULLIVAN</Name>
      <Phone>7347691331</Phone>
      <DatePrepared>2012-06-21</DatePrepared>
    </Preparer>
    <TaxYear>2011</TaxYear>
    <BuildTS>2016-02-24 21:20:13Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCount="7">
    <IRS990 documentId="RetDoc5" referenceDocumentId="RetDoc8">
      <NameOfPrincipalOfficerPerson>DENISE REINKE</NameOfPrincipalOfficerPerson>
      <AddressPrincipalOfficerUS>
        <AddressLine1>24 FRANK LLOYD WRIGHT DRIVE</AddressLine1>
        <City>ANN ARBOR</City>
        <State>MI</State>
        <ZIPCode>48106</ZIPCode>
      </AddressPrincipalOfficerUS>
      <GrossReceipts>6652670</GrossReceipts>
      <GroupReturnForAffiliates>false</GroupReturnForAffiliates>
      <Organization501c3>X</Organization501c3>
      <WebSite>WWW.SARCTRIALS.ORG</WebSite>
      <TypeOfOrganizationCorporation>X</TypeOfOrganizationCorporation>
      <YearFormation>2004</YearFormation>
      <StateLegalDomicile>MI</StateLegalDomicile>
      <ActivityOrMissionDescription>THE MISSION OF SARC IS TO: FURTHER THE SCIENTIFIC KNOWLEDGE REGARDING DIAGNOSIS AND TREATMENT OF SARCOMA; COLLABORATE WITH EXPERTS TO DESIGN COST EFFECTIVE AND EFFICIENTLY EXECUTED CLINICAL TRIALS; PROVIDE THE MOST UP- TO-DATE INFORMATION TO PHYSICIANS, PATIENTS, AND CAREGIVERS.</ActivityOrMissionDescription>
      <NbrVotingMembersGoverningBody>4</NbrVotingMembersGoverningBody>
      <NbrIndependentVotingMembers>4</NbrIndependentVotingMembers>
      <TotalNbrEmployees>9</TotalNbrEmployees>
      <TotalNbrVolunteers>20</TotalNbrVolunteers>
      <TotalGrossUBI>0</TotalGrossUBI>
      <ContributionsGrantsPriorYear>308710</ContributionsGrantsPriorYear>
      <ContributionsGrantsCurrentYear>259708</ContributionsGrantsCurrentYear>
      <ProgramServiceRevenuePriorYear>7307995</ProgramServiceRevenuePriorYear>
      <ProgramServiceRevenueCY>6333064</ProgramServiceRevenueCY>
      <InvestmentIncomePriorYear>107734</InvestmentIncomePriorYear>
      <InvestmentIncomeCurrentYear>59898</InvestmentIncomeCurrentYear>
      <OtherRevenueCurrentYear>0</OtherRevenueCurrentYear>
      <TotalRevenuePriorYear>7724439</TotalRevenuePriorYear>
      <TotalRevenueCurrentYear>6652670</TotalRevenueCurrentYear>
      <GrantsAndSimilarAmntsPriorYear>200000</GrantsAndSimilarAmntsPriorYear>
      <GrantsAndSimilarAmntsCY>200000</GrantsAndSimilarAmntsCY>
      <BenefitsPaidToMembersCY>0</BenefitsPaidToMembersCY>
      <SalariesEtcPriorYear>843514</SalariesEtcPriorYear>
      <SalariesEtcCurrentYear>789391</SalariesEtcCurrentYear>
      <TotalProfFundrsngExpCY>0</TotalProfFundrsngExpCY>
      <TotalFundrsngExpCurrentYear>0</TotalFundrsngExpCurrentYear>
      <OtherExpensePriorYear>2202965</OtherExpensePriorYear>
      <OtherExpensesCurrentYear>1748582</OtherExpensesCurrentYear>
      <TotalExpensesPriorYear>3246479</TotalExpensesPriorYear>
      <TotalExpensesCurrentYear>2737973</TotalExpensesCurrentYear>
      <RevenuesLessExpensesPriorYear>4477960</RevenuesLessExpensesPriorYear>
      <RevenuesLessExpensesCY>3914697</RevenuesLessExpensesCY>
      <TotalAssetsBOY>15305615</TotalAssetsBOY>
      <TotalAssetsEOY>14403028</TotalAssetsEOY>
      <TotalLiabilitiesBOY>5652857</TotalLiabilitiesBOY>
      <TotalLiabilitiesEOY>835573</TotalLiabilitiesEOY>
      <NetAssetsOrFundBalancesBOY>9652758</NetAssetsOrFundBalancesBOY>
      <NetAssetsOrFundBalancesEOY>13567455</NetAssetsOrFundBalancesEOY>
      <InfoInScheduleOPartIII>X</InfoInScheduleOPartIII>
      <MissionDescription>THE MISSION OF SARC IS TO: FURTHER THE SCIENTIFIC KNOWLEDGE REGARDING DIAGNOSIS AND TREATMENT OF SARCOMA; COLLABORATE WITH EXPERTS TO DESIGN COST EFFECTIVE AND EFFICIENTLY EXECUTED CLINICAL TRIALS; PROVIDE THE MOST UP- TO-DATE INFORMATION TO PHYSICIANS, PATIENTS, AND CAREGIVERS.</MissionDescription>
      <SignificantNewProgramServices>false</SignificantNewProgramServices>
      <SignificantChange>false</SignificantChange>
      <Expense>1655715</Expense>
      <Revenue>3534176</Revenue>
      <Description>COLLABORATION WITH OTHER MEDICAL INSTITUTIONS IN CONDUCTING CLINICAL TRIALS FOR THE TREATMENT OF SARCOMA.</Description>
      <Activity2>
        <Expense>207227</Expense>
        <Grants>200000</Grants>
        <Revenue>1486740</Revenue>
        <Description>PROGRAMS TO HELP SUPPORT CLINICIAN-SCIENTISTS BY PROVIDING GRANTS FOR SARCOMA TREATMENT RESEARCH.</Description>
      </Activity2>
      <Activity3>
        <Expense>110616</Expense>
        <Revenue>1351023</Revenue>
        <Description>CREATION OF A UNIFIED DATABASE SYSTEM THAT WILL CONSOLIDATE CLINICAL TRIAL FINDINGS AND ALLOW ACCESS BY SARCOMA RESEARCHERS AND CLINICIANS.</Description>
      </Activity3>
      <ActivityOther>
        <Expense>61272</Expense>
        <Revenue>200811</Revenue>
        <Description>EDUCATION AND EMPOWERMENT OF PATIENTS, CAREGIVERS AND MEDICAL PROFESSIONALS IN THE TREATMENT OF SARCOMA</Description>
      </ActivityOther>
      <TotalOfOtherProgramServiceExp>61272</TotalOfOtherProgramServiceExp>
      <TotalOfOtherProgramServiceRev>200811</TotalOfOtherProgramServiceRev>
      <TotalProgramServiceExpense>2034830</TotalProgramServiceExpense>
      <DescribedIn501C3 referenceDocumentId="RetDoc3">true</DescribedIn501C3>
      <ScheduleBRequired referenceDocumentId="RetDoc1">true</ScheduleBRequired>
      <PoliticalActivities>false</PoliticalActivities>
      <LobbyingActivities>false</LobbyingActivities>
      <SubjectToProxyTax>false</SubjectToProxyTax>
      <DonorAdvisedFunds referenceDocumentId="RetDoc4">false</DonorAdvisedFunds>
      <ConservationEasements referenceDocumentId="RetDoc4">false</ConservationEasements>
      <CollectionsOfArt referenceDocumentId="RetDoc4">false</CollectionsOfArt>
      <CreditCounseling referenceDocumentId="RetDoc4">false</CreditCounseling>
      <TermOrPermanentEndowments referenceDocumentId="RetDoc4">false</TermOrPermanentEndowments>
      <ReportLandBldgEquip referenceDocumentId="RetDoc4">true</ReportLandBldgEquip>
      <ReportInvestOthSecurities referenceDocumentId="RetDoc4">false</ReportInvestOthSecurities>
      <ReportProgRelInvest referenceDocumentId="RetDoc4">false</ReportProgRelInvest>
      <ReportOtherAssets referenceDocumentId="RetDoc4">false</ReportOtherAssets>
      <ReportOtherLiabilities referenceDocumentId="RetDoc4">true</ReportOtherLiabilities>
      <ReportFin48Footnote referenceDocumentId="RetDoc4">true</ReportFin48Footnote>
      <IndependentAuditFinancialStmt referenceDocumentId="RetDoc4">true</IndependentAuditFinancialStmt>
      <ConsolidatedAuditFinancialStmt referenceDocumentId="RetDoc4">false</ConsolidatedAuditFinancialStmt>
      <School>false</School>
      <ForeignOffice>false</ForeignOffice>
      <ForeignActivities>false</ForeignActivities>
      <MoreThan5000KToOrganizations>false</MoreThan5000KToOrganizations>
      <MoreThan5000KToIndividuals>false</MoreThan5000KToIndividuals>
      <ProfessionalFundraising>false</ProfessionalFundraising>
      <FundraisingActivities>false</FundraisingActivities>
      <Gaming>false</Gaming>
      <Hospital>false</Hospital>
      <GrantsToOrganizations referenceDocumentId="RetDoc6">false</GrantsToOrganizations>
      <GrantsToIndividuals referenceDocumentId="RetDoc6">true</GrantsToIndividuals>
      <ScheduleJRequired referenceDocumentId="RetDoc7">true</ScheduleJRequired>
      <TaxExemptBonds>false</TaxExemptBonds>
      <ExcessBenefitTransaction>false</ExcessBenefitTransaction>
      <PriorExcessBenefitTransaction>false</PriorExcessBenefitTransaction>
      <LoanToOfficerOrDQP>false</LoanToOfficerOrDQP>
      <GrantToRelatedPerson>false</GrantToRelatedPerson>
      <BsnssRltnshpWithOrganization>false</BsnssRltnshpWithOrganization>
      <BsnssRltnshpThruFamilyMember>false</BsnssRltnshpThruFamilyMember>
      <OfficerEntityWithBsnssRltnshp>false</OfficerEntityWithBsnssRltnshp>
      <DeductibleNonCashContributions>false</DeductibleNonCashContributions>
      <DeductibleContributionsOfArt>false</DeductibleContributionsOfArt>
      <Terminated>false</Terminated>
      <PartialLiquidation>false</PartialLiquidation>
      <DisregardedEntity>false</DisregardedEntity>
      <RelatedEntity>false</RelatedEntity>
      <RelatedOrgControlledEntity>false</RelatedOrgControlledEntity>
      <TransactionRelatedEntity>false</TransactionRelatedEntity>
      <TransfersToExemptNonChrtblOrg>false</TransfersToExemptNonChrtblOrg>
      <ActivitiesConductedPartnership>false</ActivitiesConductedPartnership>
      <ScheduleORequired>true</ScheduleORequired>
      <NumberFormsTransmittedWith1096>11</NumberFormsTransmittedWith1096>
      <NumberW2GIncluded>0</NumberW2GIncluded>
      <NumberOfEmployees>9</NumberOfEmployees>
      <EmploymentTaxReturnsFiled>true</EmploymentTaxReturnsFiled>
      <UnrelatedBusinessIncome>false</UnrelatedBusinessIncome>
      <ForeignFinancialAccount>false</ForeignFinancialAccount>
      <ProhibitedTaxShelterTrans>false</ProhibitedTaxShelterTrans>
      <TaxablePartyNotification>false</TaxablePartyNotification>
      <NonDeductibleContributions>false</NonDeductibleContributions>
      <QuidProQuoContributions>false</QuidProQuoContributions>
      <Form8282PropertyDisposedOf>false</Form8282PropertyDisposedOf>
      <FundsToPayPremiums>false</FundsToPayPremiums>
      <PremiumsPaid>true</PremiumsPaid>
      <IndoorTanningServices>false</IndoorTanningServices>
      <InfoInScheduleOPartVI>X</InfoInScheduleOPartVI>
      <NbrVotingGoverningBodyMembers>4</NbrVotingGoverningBodyMembers>
      <NumberIndependentVotingMembers>4</NumberIndependentVotingMembers>
      <FamilyOrBusinessRelationship>false</FamilyOrBusinessRelationship>
      <DelegationOfManagementDuties>false</DelegationOfManagementDuties>
      <ChangesToOrganizingDocs>false</ChangesToOrganizingDocs>
      <MaterialDiversionOrMisuse>false</MaterialDiversionOrMisuse>
      <MembersOrStockholders>false</MembersOrStockholders>
      <ElectionOfBoardMembers>false</ElectionOfBoardMembers>
      <DecisionsSubjectToApproval>false</DecisionsSubjectToApproval>
      <MinutesOfGoverningBody>true</MinutesOfGoverningBody>
      <MinutesOfCommittees>true</MinutesOfCommittees>
      <OfficerMailingAddress>false</OfficerMailingAddress>
      <LocalChapters>false</LocalChapters>
      <Form990ProvidedToGoverningBody>true</Form990ProvidedToGoverningBody>
      <ConflictOfInterestPolicy>true</ConflictOfInterestPolicy>
      <AnnualDisclosureCoveredPersons>true</AnnualDisclosureCoveredPersons>
      <RegularMonitoringEnforcement>true</RegularMonitoringEnforcement>
      <WhistleblowerPolicy>true</WhistleblowerPolicy>
      <DocumentRetentionPolicy>true</DocumentRetentionPolicy>
      <CompensationProcessCEO>true</CompensationProcessCEO>
      <CompensationProcessOther>true</CompensationProcessOther>
      <InvestmentInJointVenture>false</InvestmentInJointVenture>
      <StatesWhereCopyOfReturnIsFiled>MI</StatesWhereCopyOfReturnIsFiled>
      <UponRequest>X</UponRequest>
      <TheBooksAreInCareOf>
        <NamePerson>DENISE REINKE</NamePerson>
        <TelephoneNumber>7349307600</TelephoneNumber>
        <AddressUS>
          <AddressLine1>24 FRANK LLOYD WRIGHT DR</AddressLine1>
          <AddressLine2>SUITE 3100</AddressLine2>
          <City>ANN ARBOR</City>
          <State>MI</State>
          <ZIPCode>48106</ZIPCode>
        </AddressUS>
      </TheBooksAreInCareOf>
      <Form990PartVIISectionA>
        <NamePerson>MCHENRY TICHENOR</NamePerson>
        <Title>CHAIRMAN</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>MARK THORNTON MD PHD</NamePerson>
        <Title>TRUSTEE</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>KAREN ANTMAN</NamePerson>
        <Title>TRUSTEE</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>KAPIL DHINGRA</NamePerson>
        <Title>TRUSTEE</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>LEE HELMAN MD</NamePerson>
        <Title>CONSULTANT</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>DENISE REINKE</NamePerson>
        <Title>PRESIDENT/CO</Title>
        <AverageHoursPerWeek>40.00</AverageHoursPerWeek>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>218024</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>22000</OtherCompensation>
      </Form990PartVIISectionA>
      <TotalReportableCompFromOrg>218024</TotalReportableCompFromOrg>
      <TotalOtherCompensation>22000</TotalOtherCompensation>
      <NumberIndividualsGT100K>1</NumberIndividualsGT100K>
      <FormersListed>false</FormersListed>
      <TotalCompGT150K>true</TotalCompGT150K>
      <CompensationFromOtherSources>false</CompensationFromOtherSources>
      <ContractorCompensation>
        <NameOfContractor>
          <NameBusiness>
            <BusinessNameLine1>CANCER RESEARCH AND BIOSTATISTICS</BusinessNameLine1>
          </NameBusiness>
        </NameOfContractor>
        <AddressOfContractor>
          <AddressUS>
            <AddressLine1>1730 MINOR AVE SUITE 1900</AddressLine1>
            <City>SEATTLE</City>
            <State>WA</State>
            <ZIPCode>981011468</ZIPCode>
          </AddressUS>
        </AddressOfContractor>
        <DescriptionOfServices>DATABASE MNGMT</DescriptionOfServices>
        <Compensation>360015</Compensation>
      </ContractorCompensation>
      <ContractorCompensation>
        <NameOfContractor>
          <NameBusiness>
            <BusinessNameLine1>UCL HOSPITAL NHS TRUST</BusinessNameLine1>
          </NameBusiness>
        </NameOfContractor>
        <AddressOfContractor>
          <AddressForeign>
            <AddressLine1>140 HAMPLSTEAD ROAD</AddressLine1>
            <City>LONDON</City>
            <Country>UK</Country>
            <PostalCode>NW12BX</PostalCode>
          </AddressForeign>
        </AddressOfContractor>
        <DescriptionOfServices>SARCOMA RESEARC</DescriptionOfServices>
        <Compensation>200000</Compensation>
      </ContractorCompensation>
      <ContractorCompensation>
        <NameOfContractor>
          <NameBusiness>
            <BusinessNameLine1>COVANCE INC</BusinessNameLine1>
          </NameBusiness>
        </NameOfContractor>
        <AddressOfContractor>
          <AddressUS>
            <AddressLine1>PO BOX 820805</AddressLine1>
            <City>PHILADELPHIA</City>
            <State>PA</State>
            <ZIPCode>191820805</ZIPCode>
          </AddressUS>
        </AddressOfContractor>
        <DescriptionOfServices>TRIAL MNGMT</DescriptionOfServices>
        <Compensation>176888</Compensation>
      </ContractorCompensation>
      <ContractorCompensation>
        <NameOfContractor>
          <NameBusiness>
            <BusinessNameLine1>ELIASSEN GROUP</BusinessNameLine1>
          </NameBusiness>
        </NameOfContractor>
        <AddressOfContractor>
          <AddressUS>
            <AddressLine1>30 AUDUBON ROAD</AddressLine1>
            <City>WAKEFIELD</City>
            <State>MA</State>
            <ZIPCode>01880</ZIPCode>
          </AddressUS>
        </AddressOfContractor>
        <DescriptionOfServices>DATABASE DEVELO</DescriptionOfServices>
        <Compensation>155430</Compensation>
      </ContractorCompensation>
      <ContractorCompensation>
        <NameOfContractor>
          <NameBusiness>
            <BusinessNameLine1>MD ANDERSON CANCER CENTER</BusinessNameLine1>
          </NameBusiness>
        </NameOfContractor>
        <AddressOfContractor>
          <AddressUS>
            <AddressLine1>PO BOX 390</AddressLine1>
            <City>HOUSTON</City>
            <State>TX</State>
            <ZIPCode>770104390</ZIPCode>
          </AddressUS>
        </AddressOfContractor>
        <DescriptionOfServices>SARCOMA RESEARC</DescriptionOfServices>
        <Compensation>153859</Compensation>
      </ContractorCompensation>
      <NumberOfContractorsGT100K>8</NumberOfContractorsGT100K>
      <AllOtherContributions>259708</AllOtherContributions>
      <TotalContributions>259708</TotalContributions>
      <ProgramServiceRevenue>
        <Description>MEDICAL RESEARCH &amp; EDUCATION</Description>
        <BusinessCode>621500</BusinessCode>
        <TotalRevenueColumn>6333064</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>6333064</RelatedOrExemptFunctionIncome>
      </ProgramServiceRevenue>
      <TotalProgramServiceRevenue>6333064</TotalProgramServiceRevenue>
      <InvestmentIncome>
        <TotalRevenueColumn>59898</TotalRevenueColumn>
        <ExclusionAmount>59898</ExclusionAmount>
      </InvestmentIncome>
      <TotalRevenue>
        <TotalRevenueColumn>6652670</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>6333064</RelatedOrExemptFunctionIncome>
        <ExclusionAmount>59898</ExclusionAmount>
      </TotalRevenue>
      <GrantsToDomesticIndividuals>
        <Total>200000</Total>
        <ProgramServices>200000</ProgramServices>
      </GrantsToDomesticIndividuals>
      <CompCurrentOfficersDirectors>
        <Total>218023</Total>
        <ProgramServices>87209</ProgramServices>
        <ManagementAndGeneral>130814</ManagementAndGeneral>
      </CompCurrentOfficersDirectors>
      <OtherSalariesAndWages>
        <Total>459477</Total>
        <ProgramServices>227910</ProgramServices>
        <ManagementAndGeneral>231567</ManagementAndGeneral>
      </OtherSalariesAndWages>
      <PensionPlanContributions>
        <Total>61057</Total>
        <ProgramServices>25033</ProgramServices>
        <ManagementAndGeneral>36024</ManagementAndGeneral>
      </PensionPlanContributions>
      <OtherEmployeeBenefits>
        <Total>21633</Total>
        <ManagementAndGeneral>21633</ManagementAndGeneral>
      </OtherEmployeeBenefits>
      <PayrollTaxes>
        <Total>29201</Total>
        <ProgramServices>11972</ProgramServices>
        <ManagementAndGeneral>17229</ManagementAndGeneral>
      </PayrollTaxes>
      <FeesForServicesManagement>
        <Total>278192</Total>
        <ProgramServices>235384</ProgramServices>
        <ManagementAndGeneral>42808</ManagementAndGeneral>
      </FeesForServicesManagement>
      <FeesForServicesLegal>
        <Total>73713</Total>
        <ProgramServices>61919</ProgramServices>
        <ManagementAndGeneral>11794</ManagementAndGeneral>
      </FeesForServicesLegal>
      <FeesForServicesAccounting>
        <Total>20500</Total>
        <ProgramServices>15833</ProgramServices>
        <ManagementAndGeneral>4667</ManagementAndGeneral>
      </FeesForServicesAccounting>
      <FeesForServicesOther>
        <Total>16063</Total>
        <ManagementAndGeneral>16063</ManagementAndGeneral>
      </FeesForServicesOther>
      <Advertising>
        <Total>2411</Total>
        <ProgramServices>1464</ProgramServices>
        <ManagementAndGeneral>947</ManagementAndGeneral>
      </Advertising>
      <OfficeExpenses>
        <Total>20837</Total>
        <ProgramServices>8400</ProgramServices>
        <ManagementAndGeneral>12437</ManagementAndGeneral>
      </OfficeExpenses>
      <InformationTechnology>
        <Total>25194</Total>
        <ProgramServices>3752</ProgramServices>
        <ManagementAndGeneral>21442</ManagementAndGeneral>
      </InformationTechnology>
      <Occupancy>
        <Total>61438</Total>
        <ManagementAndGeneral>61438</ManagementAndGeneral>
      </Occupancy>
      <Travel>
        <Total>44764</Total>
        <ProgramServices>37046</ProgramServices>
        <ManagementAndGeneral>7718</ManagementAndGeneral>
      </Travel>
      <ConferencesMeetings>
        <Total>79598</Total>
        <ProgramServices>69247</ProgramServices>
        <ManagementAndGeneral>10351</ManagementAndGeneral>
      </ConferencesMeetings>
      <DepreciationDepletion>
        <Total>31855</Total>
        <ManagementAndGeneral>31855</ManagementAndGeneral>
      </DepreciationDepletion>
      <Insurance>
        <Total>61273</Total>
        <ProgramServices>16917</ProgramServices>
        <ManagementAndGeneral>44356</ManagementAndGeneral>
      </Insurance>
      <OtherExpenses>
        <Description>CLINICAL TRIAL COST &amp; SIT</Description>
        <Total>1032744</Total>
        <ProgramServices>1032744</ProgramServices>
      </OtherExpenses>
      <TotalFunctionalExpenses>
        <Total>2737973</Total>
        <ProgramServices>2034830</ProgramServices>
        <ManagementAndGeneral>703143</ManagementAndGeneral>
        <Fundraising>0</Fundraising>
      </TotalFunctionalExpenses>
      <CashNonInterestBearing>
        <BOY>816100</BOY>
        <EOY>573487</EOY>
      </CashNonInterestBearing>
      <SavingsAndTempCashInvestments>
        <BOY>13885058</BOY>
        <EOY>13272738</EOY>
      </SavingsAndTempCashInvestments>
      <AccountsReceivable>
        <BOY>195463</BOY>
        <EOY>243067</EOY>
      </AccountsReceivable>
      <PrepaidExpensesDeferredCharges>
        <BOY>21916</BOY>
        <EOY>22721</EOY>
      </PrepaidExpensesDeferredCharges>
      <LandBuildingsEquipmentBasis>404789</LandBuildingsEquipmentBasis>
      <LandBldgEquipmentAccumDeprec>151184</LandBldgEquipmentAccumDeprec>
      <LandBuildingsEquipmentBasisNet>
        <BOY>285460</BOY>
        <EOY>253605</EOY>
      </LandBuildingsEquipmentBasisNet>
      <OtherAssetsTotal>
        <BOY>101618</BOY>
        <EOY>37410</EOY>
      </OtherAssetsTotal>
      <TotalAssets>
        <BOY>15305615</BOY>
        <EOY>14403028</EOY>
      </TotalAssets>
      <AccountsPayableAccruedExpenses>
        <BOY>1571368</BOY>
        <EOY>551880</EOY>
      </AccountsPayableAccruedExpenses>
      <DeferredRevenue>
        <BOY>4079531</BOY>
        <EOY>282028</EOY>
      </DeferredRevenue>
      <OtherLiabilities>
        <BOY>1958</BOY>
        <EOY>1665</EOY>
      </OtherLiabilities>
      <TotalLiabilities>
        <BOY>5652857</BOY>
        <EOY>835573</EOY>
      </TotalLiabilities>
      <FollowSFAS117>X</FollowSFAS117>
      <UnrestrictedNetAssets>
        <BOY>7964923</BOY>
        <EOY>7623245</EOY>
      </UnrestrictedNetAssets>
      <TemporarilyRestrictedNetAssets>
        <BOY>1687835</BOY>
        <EOY>5944210</EOY>
      </TemporarilyRestrictedNetAssets>
      <TotalNetAssetsFundBalances>
        <BOY>9652758</BOY>
        <EOY>13567455</EOY>
      </TotalNetAssetsFundBalances>
      <TotalLiabNetAssetsFundBalances>
        <BOY>15305615</BOY>
        <EOY>14403028</EOY>
      </TotalLiabNetAssetsFundBalances>
      <ReconcilationRevenueExpenses>3914697</ReconcilationRevenueExpenses>
      <MethodOfAccountingAccrual>X</MethodOfAccountingAccrual>
      <AccountantCompileOrReview>false</AccountantCompileOrReview>
      <FSAudited>true</FSAudited>
      <AuditCommittee>true</AuditCommittee>
      <FinancialStatementConsolidated>X</FinancialStatementConsolidated>
      <FederalGrantAuditRequired>false</FederalGrantAuditRequired>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc3">
      <PubliclySupportedOrg170b1Avi>X</PubliclySupportedOrg170b1Avi>
      <GiftsGrantsContribReceived170>
        <CurrentTaxYearMinus4Years>2044374</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>1159491</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>2779580</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>308710</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>259708</CurrentTaxYear>
        <Total>6551863</Total>
      </GiftsGrantsContribReceived170>
      <Total170>
        <CurrentTaxYearMinus4Years>2044374</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>1159491</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>2779580</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>308710</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>259708</CurrentTaxYear>
        <Total>6551863</Total>
      </Total170>
      <AmountsSubstContributorsTotal>3726645</AmountsSubstContributorsTotal>
      <PublicSupportTotal170>2825218</PublicSupportTotal170>
      <GrossInvestmentIncome170>
        <CurrentTaxYearMinus4Years>50685</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>110291</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>102945</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>107734</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>59898</CurrentTaxYear>
        <Total>431553</Total>
      </GrossInvestmentIncome170>
      <OtherIncome170>
        <CurrentTaxYearMinus4Years>400</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>15381</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus1Year>13301</CurrentTaxYearMinus1Year>
        <Total>29082</Total>
      </OtherIncome170>
      <TotalSupport>7012498</TotalSupport>
      <GrossReceiptsFromAdmissionsEtc>6333064</GrossReceiptsFromAdmissionsEtc>
      <PublicSupportPertcentage170>0.40290</PublicSupportPertcentage170>
      <PublicSupportPertcentPriorYear>0.40530</PublicSupportPertcentPriorYear>
      <ThirtyThreePercntTestsCY170>X</ThirtyThreePercntTestsCY170>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1">
      <ContributorInfo>
        <ContributorNumber>RESTRICTED</ContributorNumber>
        <ContributorNameBusiness>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorNameBusiness>
        <ContributorAddressUS>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorAddressUS>
        <AggregateContributions>RESTRICTED</AggregateContributions>
      </ContributorInfo>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc4">
      <DisclosedOrgsLegalControl>false</DisclosedOrgsLegalControl>
      <DisclosedForCharitablePurposes>false</DisclosedForCharitablePurposes>
      <WrittenPolicyMonitoring>false</WrittenPolicyMonitoring>
      <Sect170hRequirementsSatisfied>false</Sect170hRequirementsSatisfied>
      <SolicitedAssetsForSale>false</SolicitedAssetsForSale>
      <AgentTrusteeEtc>false</AgentTrusteeEtc>
      <IncludedOnFS>false</IncludedOnFS>
      <EndowmentsHeldByUnrelatedOrgs>false</EndowmentsHeldByUnrelatedOrgs>
      <EndowmentsHeldByRelatedOrgs>false</EndowmentsHeldByRelatedOrgs>
      <AreRelatedOrgsListedScheduleR>false</AreRelatedOrgsListedScheduleR>
      <LeaseholdImprovements>
        <OtherCostOrOtherBasis>176733</OtherCostOrOtherBasis>
        <Depreciation>19452</Depreciation>
        <BookValue>157281</BookValue>
      </LeaseholdImprovements>
      <Equipment>
        <OtherCostOrOtherBasis>228056</OtherCostOrOtherBasis>
        <Depreciation>131732</Depreciation>
        <BookValue>96324</BookValue>
      </Equipment>
      <TotalOfBookValueLandBuildings>253605</TotalOfBookValueLandBuildings>
      <OtherLiabilities>
        <Description>ACCRUED PAYROLL</Description>
        <Amount>1665</Amount>
      </OtherLiabilities>
      <TotalOfAmounts>1665</TotalOfAmounts>
      <TotalRevenue>6652670</TotalRevenue>
      <TotalExpenses>2737973</TotalExpenses>
      <ExcessOrDeficitForYear>3914697</ExcessOrDeficitForYear>
      <ExcessOrDeficitPerFS>3914697</ExcessOrDeficitPerFS>
      <TotRevenueEtcAuditedFinclStmt>6857245</TotRevenueEtcAuditedFinclStmt>
      <DonatedSrvcAndUseOfFacilities>204575</DonatedSrvcAndUseOfFacilities>
      <RevenueNotRptdF990>204575</RevenueNotRptdF990>
      <RevenueSubtotal>6652670</RevenueSubtotal>
      <TotalRevenuePerForm990>6652670</TotalRevenuePerForm990>
      <TotExpensesEtcAuditedFinclStmt>2942548</TotExpensesEtcAuditedFinclStmt>
      <DonatedServicesUseOfFacilities>204575</DonatedServicesUseOfFacilities>
      <ExpensesNotRptdF990>204575</ExpensesNotRptdF990>
      <ExpensesSubtotal>2737973</ExpensesSubtotal>
      <TotalExpensesPerForm990>2737973</TotalExpensesPerForm990>
      <Form990ScheduleDPartXIV>
        <Identifier>LIABILITY UNDER FIN 48 FOOTNOTE</Identifier>
        <ReturnReference>SCHEDULE D, PAGE 3, PART X</ReturnReference>
        <Explanation>THE ORGANIZATION IS EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C) (3) OF THE INTERNAL REVENUE CODE. THE ORGANIZATION HAS NO UNRELATED BUSINESS INCOME. ACCORDINGLY, NO PROVISION FOR INCOME TAXES HAS BEEN RECORDED. THE ORGANIZATION FILES INFORMATIONAL RETURNS IN THE U.S. FEDERAL JURISDICTION AND STATE OF MICHIGAN. GENERALLY, THE STATUE OF LIMITATIONS OF FEDERAL RETURNS EXPIRES AFTER 3 YEARS AND OF MICHIGAN RETURNS AFTER 4 YEARS.</Explanation>
      </Form990ScheduleDPartXIV>
    </IRS990ScheduleD>
    <IRS990ScheduleI documentId="RetDoc6">
      <RecordsMaintained>false</RecordsMaintained>
      <Form990ScheduleIPartIII>
        <TypeOfGrant>CAREER DEVELOPMENT AWARD</TypeOfGrant>
        <NumberOfRecipients>2</NumberOfRecipients>
        <AmountOfCashGrant>200000</AmountOfCashGrant>
      </Form990ScheduleIPartIII>
      <Form990ScheduleIPartIV>
        <Identifier>PROCEDURES FOR MONITORING THE USE OF GRANT FUNDS INSIDE THE UNITED STATES</Identifier>
        <ReturnReference>SCHEDULE I, PAGE 1, PART I, LINE 2</ReturnReference>
        <Explanation>100,000 OFFERED PER YEAR FOR UP TO THREE YEARS. FUNDS ARE AWARDED AS A ONE-YEAR GRANT, RENEWABLE FOR ADDITIONAL TWO YEARS MAXIMUM. AWARDEE PROVIDES AN ANNUAL PROGRESS REPORT AND MENTOR REPORT THAT ARE REVIEWED BY COMMITTEE ANNUALLY THROUGH RENEWAL AND COMPLETION.</Explanation>
      </Form990ScheduleIPartIV>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="RetDoc7">
      <FirstClassOrCharterTravel>X</FirstClassOrCharterTravel>
      <WrittenPolicyReTAndEExpenses>true</WrittenPolicyReTAndEExpenses>
      <SubstantiationRequired>false</SubstantiationRequired>
      <CompensationCommittee>X</CompensationCommittee>
      <IndependentConsultant>X</IndependentConsultant>
      <WrittenEmploymentContract>X</WrittenEmploymentContract>
      <CompensationSurvey>X</CompensationSurvey>
      <BoardOrCommitteeApproval>X</BoardOrCommitteeApproval>
      <SeverancePayment>false</SeverancePayment>
      <SupplementalNonqualRetirePlan>false</SupplementalNonqualRetirePlan>
      <EquityBasedCompArrangement>false</EquityBasedCompArrangement>
      <CompBasedOnRevenueOfFilingOrg>false</CompBasedOnRevenueOfFilingOrg>
      <CompBasedOnRevenueRelatedOrgs>false</CompBasedOnRevenueRelatedOrgs>
      <CompBasedNetEarningsFilingOrg>false</CompBasedNetEarningsFilingOrg>
      <CompBasedNetEarningsRelateOrgs>false</CompBasedNetEarningsRelateOrgs>
      <AnyNonFixedPayments>false</AnyNonFixedPayments>
      <InitialContractException>false</InitialContractException>
      <Form990ScheduleJPartII>
        <NamePerson>DENISE REINKE</NamePerson>
        <BaseCompensationFilingOrg>218024</BaseCompensationFilingOrg>
        <DeferredCompFilingOrg>22000</DeferredCompFilingOrg>
        <TotalCompensationFilingOrg>240024</TotalCompensationFilingOrg>
      </Form990ScheduleJPartII>
    </IRS990ScheduleJ>
    <IRS990ScheduleO documentId="RetDoc8">
      <GeneralExplanation>
        <Identifier>ORGANIZATION'S MISSION</Identifier>
        <ReturnReference>FORM 990 - ORGANIZATION'S MISSION</ReturnReference>
        <Explanation>THE MISSION OF SARC IS TO: FURTHER THE SCIENTIFIC KNOWLEDGE REGARDING DIAGNOSIS AND TREATMENT OF SARCOMA; COLLABORATE WITH EXPERTS TO DESIGN COST EFFECTIVE AND EFFICIENTLY EXECUTED CLINICAL TRIALS; PROVIDE THE MOST UP- TO-DATE INFORMATION TO PHYSICIANS, PATIENTS, AND CAREGIVERS.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>ALL OTHER ACCOMPLISHMENT DESCRIPTION</Identifier>
        <ReturnReference>FORM 990, PAGE 2, PART III, LINE 4D</ReturnReference>
        <Explanation>EDUCATION AND EMPOWERMENT OF PATIENTS, CAREGIVERS AND MEDICAL PROFESSIONALS IN THE TREATMENT OF SARCOMA</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>ORGANIZATION'S PROCESS USED TO REVIEW FORM 990</Identifier>
        <ReturnReference>FORM 990, PAGE 6, PART VI, LINE 11B</ReturnReference>
        <Explanation>THE FINANCE COMMITTEE, THE PRESIDENT AND THE FINANCE MANAGER PERFORM A DETAILED REVIEW.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>ENFORCEMENT OF CONFLICTS POLICY</Identifier>
        <ReturnReference>FORM 990, PAGE 6, PART VI, LINE 12C</ReturnReference>
        <Explanation>THE ORGANIZATION'S CONFLICT OF INTEREST POLICY IS MADE PART OF THE EMPLOYEE'S PERSONNEL MANUAL WHICH IS REQUIRED READING FOR ALL EMPLOYEES, DIRECTORS AND BOARD MEMBERS.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>COMPENSATION PROCESS FOR TOP OFFICIAL</Identifier>
        <ReturnReference>FORM 990, PAGE 6, PART VI, LINE 15A</ReturnReference>
        <Explanation>ORGANIZATION'S ATTORNEYS WERE CONTRACTED AS INDEPENDENT CONSULTANTS TO PERFORM COMPENSATION STUDIES FOR CERTAIN ORGANIZATION EMPLOYEES.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>COMPENSATION PROCESS FOR OFFICERS</Identifier>
        <ReturnReference>FORM 990, PAGE 6, PART VI, LINE 15B</ReturnReference>
        <Explanation>ORGANIZATION'S ATTORNEYS WERE CONTRACTED AS INDEPENDENT CONSULTANTS TO PERFORM COMPENSATION STUDIES FOR CERTAIN ORGANIZATION EMPLOYEES.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>GOVERNING DOCUMENTS DISCLOSURE EXPLANATION</Identifier>
        <ReturnReference>FORM 990, PAGE 6, PART VI, LINE 19</ReturnReference>
        <Explanation>GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE AVAILABLE UPON SPECIFIC REQUEST</Explanation>
      </GeneralExplanation>
    </IRS990ScheduleO>
  </ReturnData>
</Return>